This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Auburn University, Edward Via College of Osteopathic Medicine—auburn. Active years: 2016-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Simpsonville, SC (US) (2016)
- Auburn, AL (US) (2023)
Company Filing History:
2 out of 414 
1 out of 1 Years Active: 2016-2023
Title: James W. Gillespie: A Pioneer in Immune Response Innovations
Introduction
James W. Gillespie, an innovative inventor based in Auburn, Alabama, has made significant contributions to the field of immunology through his patents. With a total of two patents to his name, Gillespie focuses on developing novel phage-peptide constructs aimed at stimulating immune responses against CD47, a critical target in cancer immunotherapy.
Latest Patents
Gillespie's latest innovations include two noteworthy patents. The first patent revolves around "Phage-peptide constructs for stimulating an immune response against CD47." This invention details recombinant bacteriophage constructs and related exogenous peptide sequences designed to generate immune responses against CD47. These constructs can bind to antibodies targeting CD47 and are intended for administration in animals to induce specific immune reactions, including the generation of anti-CD47 antibodies.
The second patent, titled "Targeted particles comprising landscape phage fusion proteins and heterologous nucleic acid," presents targeted particles that consist of landscape phage fusion proteins complexed with heterologous nucleic acid. The landscape phage fusion proteins display heterologous peptides, and the targeted particles are designed to bind specifically to target sites, allowing for modulation of gene expression in target cells.
Career Highlights
Throughout his career, James W. Gillespie has been affiliated with notable institutions such as Auburn University and the Edward Via College of Osteopathic Medicine. His work in these esteemed organizations showcases his dedication to advancing medical research and developing innovative therapeutic strategies.
Collaborations
Gillespie has collaborated with other researchers, including Valery A. Petrenko and Deepa Bedi. These collaborations highlight the importance of teamwork in the pursuit of scientific advancements and the development of new technologies for healthcare applications.
Conclusion
James W. Gillespie stands out as a pioneering inventor in the field of immunology, with his contributions aimed at combating diseases through innovative immune response mechanisms. His patents represent significant steps forward in the quest for effective treatments, showcasing the potential of recombinant technology in medical science. As the landscape of healthcare continues to evolve, Gillespie's work will undoubtedly leave a lasting impact on future research and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile